Source: Eur Respir Rev 2017; 26: 160099
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Matteo Bonini, Giuseppe Fiorenzano. Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev 2017; 26: 160099

Member's Comments

No comment yet.

Related content which might interest you: Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing Source: Eur Respir Rev 2016; 25: 333-347 Year: 2016 Exertional dyspnoea in cardiorespiratory disorders: the clinical use of cardiopulmonary exercise testing Source: Eur Respir Rev 2016; 25: 227-229 Year: 2016 Value of cardiopulmonary exercise testing in interstitial lung diseases Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Practicality and clinical utility of cardiopulmonary exercise testing to investigate complex breathlessness in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020 Year: 2021 Cardiopulmonary excercise testing in the diagnosis of chronic unexplained dyspnoea Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Cardiopulmonary exercise testing in the early evaluation of unexplained exertional dyspnea Source: Eur Respir J 2005; 26: Suppl. 49, 347s Year: 2005 Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD Source: Eur Respir J 2009; 34: 866-874 Year: 2009 Cardiopulmonary exercise test in the evaluation of patients with unexplained dyspnea Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Severe exertional dyspnoea in COPD: Implications for exercise tolerance and survival Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD Year: 2021 Cardiopulmonary and gas-exchange responses during the 6-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Clinical exercise physiology in health and COPD Year: 2014 The value of cardiopulmonary exercise testing in sarcoidosis Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015 ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases Source: Eur Respir Rev, 28 (154) 180101; 10.1183/16000617.0101-2018 Year: 2019 The clinical management of exertional dyspnoea in patients with cardiorespiratory diseases Source: Research Seminar 2012 - Dyspnoea: multidimensional and multidisciplinary Year: 2012 Exercise testing in the evaluation of exercise intolerance in respiratory diseases Source: Annual Congress 2005 - PG4 - Respiratory physiology: exercise in clinical practice Year: 2005 Ventilatory efficiency and exercise capacity during exercise in the patients with idiopathic pulmonary fibros Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 The treatment of difficult asthmatics with no pulmonary cause for persistent symptoms on cardiopulmonary exercise testing (CPX) Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Physiological responses to cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006